BAKER BROS. ADVISORS LP – Prelude Therapeutics Incorporated Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$66.91M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+26.63%
quarter
Prelude Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 14.07M | $6.61 | 10.12M | |
| Q2 2022 | share | 0.00% | 0 shares | -17.00M | $5.22 | 10.12M | |
| Q1 2022 | share | 0.00% | 0 shares | -56.18M | $6.9 | 10.12M | |
| Q4 2021 | share | 0.00% | 0 shares | -190.32M | $12.76 | 10.12M | |
| Q3 2021 | share | 0.00% | 0 shares | 26.52M | $31.25 | 10.12M | |
| Q2 2021 | share | 0.00% | 0 shares | -148.82M | $28.63 | 10.12M | |
| Q1 2021 | share | Increase | +0.05% | 5.18K shares | -285.32M | $43.33 | 10.12M |
| Q4 2020 | share | 0.00% | 0 shares | 419.11M | $71.55 | 10.11M | |
| Q3 2020 | share | Increase | 0.00% | 10.11M shares | 304.87M | $30.13 | 10.11M |